Internal Medicine, Rheumatology · Sacramento, CA
NPI
1699063941
Since 2011
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
2
Medicare group memberships
Hospitals
0
Hospital affiliations
1651 Exposition Blvd # 302
Sacramento, CA, 95815
Phone (916) 455-3700
Groups this clinician bills Medicare through
Medicare paid, 2023
$49K
4,585 services
Medicare patients, 2023
11
Average age 55
Drug cost, 2024
$2.2M
2,136 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Mohammadomid Edrissian prescribed most often to Medicare patients was Hydroxychloroquine Sulfate, with 390 prescriptions and refills. In total Mohammadomid Edrissian wrote 2,136 Medicare prescriptions that cost $2.2M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-09-01.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Hydroxychloroquine Sulfate Generic | 390 | 1,169 | 124 | $13K |
| Prednisone Generic | 379 | 796 | 133 | $3,711 |
| Methotrexate Methotrexate Sodium | 287 | 784 | 85 | $5,890 |
| Leflunomide Generic | 135 | 411 | 42 | $4,075 |
| Enbrel Sureclick Etanercept | 135 | 135 | 15 | $729K |
| Enbrel Etanercept | 86 | 86 | Under 11 | $419K |
| Amjevita(Cf) Autoinjector Adalimumab-Atto | 83 | 83 | Under 11 | $85K |
| Cosentyx Sensoready (2 Pens) Secukinumab | 58 | 58 | Under 11 | $191K |
| Amjevita(Cf) Adalimumab-Atto | 58 | 58 | Under 11 | $67K |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 54 | 54 | Under 11 | $721 |
| Mycophenolate Mofetil Generic | 48 | 151 | 16 | $6,095 |
| Rasuvo Methotrexate/Pf | 44 | 115 | 12 | $47K |
| Sulfasalazine Generic | 37 | 108 | 11 | $2,655 |
| Methylprednisolone Generic | 37 | 62 | 12 | $630 |
| Otezla Apremilast | 27 | 27 | Under 11 | $119K |
Brand drugs: - claims; generic drugs: 1,484 claims; opioid claims: 77.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Mohammadomid Edrissian were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.